Market Overview:
The global fenbendazole market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of parasitic infections, increasing demand for generic drugs, and growing awareness about animal health and hygiene. Fenbendazole is an anthelmintic drug used for the treatment of parasitic infections in animals. It is available in different forms such as tablets, powder, and cream, depending on the application. The global fenbendazole market has been segmented on the basis of type, application, and region. On the basis of type, it has been segmented into 95% purity type, 98% purity type 99% purity type,, and others segments. On the basis of application,, it has been segmented into fenbenazole tablets,, fenbenazole powder,, and fenbenzale cream segments,. Geographically,. North America accounted for majority share in terms of revenue followed by Europe Asia Pacific , Latin America ,and Middle East & Africa . However,. Asia Pacific is expected to witness highest growth rate during forecast period owing to rising awareness about animal health & hygiene coupled with increasing demand from countries such as China India . Some key players operating in this market include Zoetis Inc., Merck Animal Health LLC., Bayer AG., Boehringer Ingelheim GmbH.
 Industry Outlook.svg)
Product Definition:
Fenbendazole is a benzimidazole anthelmintic agent used in veterinary medicine to treat parasitic nematodes, cestodes and trematodes infections in animals.
95% Purity Type:
95% Purity Type is a form of Pharmaceutical Grade Buprenorphine. It has been used as an opioid analgesic and as an alternative to morphine in the treatment of severe pain. 95% Purity Type is also known as Asfotase Alfa, it's a potent enzyme inhibitor which reduces the production of pro-inflammatory cytokines by activated immune cells called macrophages.
98% Purity Type:
98% Purity Type is a form of Pharmaceutical Grade Type which has been fully tested and certified by Therapeutic Goods Administration (TGA) for its content, quality & purity. It is used in the synthesis of Fenbendazole (Fen- BEN -dazole).
98% Purity type contains no less than 98% active pharmaceutical ingredients.
Application Insights:
Fenbenazole tablets were the major application segment and accounted for over 60% of the global market share in 2017. The product is used to treat parasitic infections, such as hookworms, ascarids and whipworms. It is also employed in dips for dogs and horses to kill intestinal worms. Furthermore, it finds applications in agriculture owing to its nematicidal properties against caterpillars that cause crop damage. These factors are anticipated to drive demand over the forecast period.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to witness significant growth over the forecast period owing to high product demand from countries, such as China and India. In addition, increasing use of fenbendazole for parasite treatment coupled with rising awareness about drug safety is anticipated to drive regional market growth over the forecast period.
The Asia Pacific was followed by Europe in terms of revenue generation in 2017 due to presence of stringent regulations regarding soil contamination and water pollution along with growing environmental concerns among consumers. Moreover, presence of a large number of manufacturers coupled with availability of quality raw materials will boost regional product demand over the projected time frame.
North America also held a considerable share owing to high awareness levels amongst farmers pertaining towards soil conservation practices resulting into less landfills generation along with lower usage rates for pesticides production leading towards higher adoption rate for fenbendazole tablets & powder forms across U S states including California.
Growth Factors:
- Increasing demand for livestock products: The global population is increasing at a rapid pace and with this the demand for livestock products is also rising. This will result in an increase in the demand for fenbendazole as it helps to improve the productivity of livestock.
- Rising awareness about animal health: There is a growing awareness among people about the importance of animal health and this is resulting in an increase in the demand for fenbendazole. It helps to improve the overall health of animals and prevents them from getting sick.
- Growing popularity of organic farming: There is a growing trend towards organic farming and this is helping to drive up the demand for fenbendazole as it can be used safely on organically certified farms without any adverse effects on crops or soil fertility levels.
- Technological advancements: The development of new technologies has helped to make fenbendazole more effective and efficient, thus driving up its demand across different markets worldwide. This has resulted in an increased acceptance of this drug by farmers, veterinarians, etc., thereby boosting its sales significantly over time.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Fenbendazole (CAS 43210-67-9) Market Research Report
By Type
95% Purity Type, 98% Purity Type, 99% Purity Type, Others
By Application
Fenbenazole Tablets, Fenbendazole Powder, Fenbenazole Cream
By Companies
Jin Dun Pharm, Shandong Zhengmu, Ramical, Kang Bao Lai Animal Pharm, Jiatai Animal Pharm, Nuowei Animal Pharm, MERCK, Safe-Guard, O.L.KAR
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Fenbendazole (CAS 43210-67-9) Market Report Segments:
The global Fenbendazole (CAS 43210-67-9) market is segmented on the basis of:
Types
95% Purity Type, 98% Purity Type, 99% Purity Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fenbenazole Tablets, Fenbendazole Powder, Fenbenazole Cream
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jin Dun Pharm
- Shandong Zhengmu
- Ramical
- Kang Bao Lai Animal Pharm
- Jiatai Animal Pharm
- Nuowei Animal Pharm
- MERCK
- Safe-Guard
- O.L.KAR
 Market Overview.svg)
Highlights of The Fenbendazole (CAS 43210-67-9) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 95% Purity Type
- 98% Purity Type
- 99% Purity Type
- Others
- By Application:
- Fenbenazole Tablets
- Fenbendazole Powder
- Fenbenazole Cream
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fenbendazole (CAS 43210-67-9) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fenbendazole is a medication used to treat parasitic infections. It works by killing the parasites. Fenbendazole is also known as mefenamic acid.
Some of the key players operating in the fenbendazole (cas 43210-67-9) market are Jin Dun Pharm, Shandong Zhengmu, Ramical, Kang Bao Lai Animal Pharm, Jiatai Animal Pharm, Nuowei Animal Pharm, MERCK, Safe-Guard, O.L.KAR.
The fenbendazole (cas 43210-67-9) market is expected to grow at a compound annual growth rate of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fenbendazole (CAS 43210-67-9) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fenbendazole (CAS 43210-67-9) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fenbendazole (CAS 43210-67-9) Market - Supply Chain
4.5. Global Fenbendazole (CAS 43210-67-9) Market Forecast
4.5.1. Fenbendazole (CAS 43210-67-9) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fenbendazole (CAS 43210-67-9) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fenbendazole (CAS 43210-67-9) Market Absolute $ Opportunity
5. Global Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Type
5.3.1. 95% Purity Type
5.3.2. 98% Purity Type
5.3.3. 99% Purity Type
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Application
6.3.1. Fenbenazole Tablets
6.3.2. Fenbendazole Powder
6.3.3. Fenbenazole Cream
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fenbendazole (CAS 43210-67-9) Demand Share Forecast, 2019-2026
9. North America Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Application
9.4.1. Fenbenazole Tablets
9.4.2. Fenbendazole Powder
9.4.3. Fenbenazole Cream
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Type
9.7.1. 95% Purity Type
9.7.2. 98% Purity Type
9.7.3. 99% Purity Type
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fenbendazole (CAS 43210-67-9) Demand Share Forecast, 2019-2026
10. Latin America Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Application
10.4.1. Fenbenazole Tablets
10.4.2. Fenbendazole Powder
10.4.3. Fenbenazole Cream
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Type
10.7.1. 95% Purity Type
10.7.2. 98% Purity Type
10.7.3. 99% Purity Type
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fenbendazole (CAS 43210-67-9) Demand Share Forecast, 2019-2026
11. Europe Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Application
11.4.1. Fenbenazole Tablets
11.4.2. Fenbendazole Powder
11.4.3. Fenbenazole Cream
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Type
11.7.1. 95% Purity Type
11.7.2. 98% Purity Type
11.7.3. 99 Purity Type
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fenbendazole (CAS 43210-67-9) Demand Share, 2019-2026
12. Asia Pacific Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Application
12.4.1. Fenbenazole Tablets
12.4.2. Fenbendazole Powder
12.4.3. Fenbenazole Cream
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Type
12.7.1. 95% Purity Type
12.7.2. 98% Purity Type
12.7.3. 99% Purity Type
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fenbendazole (CAS 43210-67-9) Demand Share, 2019-2026
13. Middle East & Africa Fenbendazole (CAS 43210-67-9) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Application
13.4.1. Fenbenazole Tablets
13.4.2. Fenbendazole Powder
13.4.3. Fenbenazole Cream
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fenbendazole (CAS 43210-67-9) Market Size and Volume Forecast by Type
13.7.1. 95% Purity Type
13.7.2. 98% Purity Type
13.7.3. 99% Purity Type
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fenbendazole (CAS 43210-67-9) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fenbendazole (CAS 43210-67-9) Market: Market Share Analysis
14.2. Fenbendazole (CAS 43210-67-9) Distributors and Customers
14.3. Fenbendazole (CAS 43210-67-9) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Jin Dun Pharm
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Shandong Zhengmu
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Ramical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Kang Bao Lai Animal Pharm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Jiatai Animal Pharm
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nuowei Animal Pharm
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MERCK
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Safe-Guard
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. O.L.KAR
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
